| 14 Nov, 01:45 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 Nov, 01:42 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 14, 2025, titled "Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial". | nse |
| 13 Nov, 07:03 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Nov, 07:01 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Closure of USFDA inspection at Zydus oncology injectable manufacturing facility in SEZ1, Ahmedabad". | nse |
| 13 Nov, 04:44 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Nov, 04:43 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Revised press release". | nse |
| 13 Nov, 01:56 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Nov, 01:54 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg". | nse |
| 13 Nov, 12:43 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Nov, 12:41 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Zydus Amplitude receives CE mark for its robotic surgical system Andy . | nse |
| 13 Nov, 11:19 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 13 Nov, 11:16 am | — | … | Zydus Lifesciences Limited has informed the Exchange about Transcript | nse |
| 11 Nov, 09:56 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 11 Nov, 09:53 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 11, 2025, titled "Zydus receives approval from China s NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg". | nse |
| 07 Nov, 06:01 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 07 Nov, 05:59 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Zydus receives tentative approval from USFDA for Olaparib Tablets, 100 mg and 150 mg". | nse |
| 06 Nov, 06:56 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 06 Nov, 06:55 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Link of Recording | nse |
| 06 Nov, 01:20 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 06 Nov, 01:19 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Investor Presentation | nse |
| 06 Nov, 01:14 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Nov, 01:12 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Raising of Funds | bse |
| 06 Nov, 01:09 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 06, 2025, titled "Financial Performance for Q2 & H1 FY26". | nse |
| 06 Nov, 01:04 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on November 06, 2025. | nse |
| 06 Nov, 01:03 pm | — | … | Zydus Lifesciences Ltd - 532321 - Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2025 | bse |
| 06 Nov, 01:03 pm | — | … | Zydus Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 06 Nov, 09:55 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Nov, 09:52 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 06, 2025, titled "Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia". | nse |
| 05 Nov, 11:16 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Nov, 11:13 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Zydus receives EIR for SEZ II manufacturing facility, Ahmedabad". | nse |
| 04 Nov, 02:39 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Nov, 02:36 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 04, 2025, titled "Zydus receives tentative approval from USFDA for Budesonide delayed release capsules, 4 mg". | nse |
| 03 Nov, 05:27 pm | — | … | Zydus Lifesciences Ltd - 532321 - Update on board meeting | bse |
| 01 Nov, 11:09 am | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 01 Nov, 11:06 am | — | … | Zydus Lifesciences Ltd - 532321 - Demand Notice From GST Department | bse |
| 29 Oct, 06:28 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Oct, 06:26 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 29, 2025, titled "Zydus receives EIR for the Baddi manufacturing facility". | nse |
| 29 Oct, 12:23 pm | — | … | Zydus Lifesciences Ltd - 532321 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2025. | bse |
| 26 Oct, 11:54 am | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 26 Oct, 11:51 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 24 Oct, 07:25 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Oct, 07:23 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 24, 2025, titled "Press Release". | nse |
| 17 Oct, 11:22 am | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 17 Oct, 11:19 am | — | … | Zydus Lifesciences Ltd - 532321 - Update | bse |
| 06 Oct, 04:25 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Oct, 04:22 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 06, 2025, titled "Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg". | nse |
| 06 Oct, 03:04 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Oct, 03:02 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 06, 2025, titled "Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL". | nse |
| 01 Oct, 05:52 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 01 Oct, 05:49 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Sentynl Therapeutics updates on its NDA for CUTX-101". | nse |